Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 118.82 billion. The enterprise value is 168.95 billion.

Market Cap	118.82B
Enterprise Value	168.95B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jan 24, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 37.45.

PE Ratio	37.45
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.67, with an EV/FCF ratio of 27.52.

EV / Earnings	53.25
EV / Sales	3.58
EV / EBITDA	10.67
EV / EBIT	18.08
EV / FCF	27.52

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.73.

Current Ratio	1.00
Quick Ratio	0.64
Debt / Equity	0.73
Debt / EBITDA	3.46
Debt / FCF	8.26
Interest Coverage	3.78

Financial Efficiency

Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is 4.46%.

Return on Equity (ROE)	4.54%
Return on Assets (ROA)	3.31%
Return on Capital (ROIC)	4.46%
Revenue Per Employee	503,507
Profits Per Employee	36,057
Employee Count	88,000
Asset Turnover	0.27
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.23%
50-Day Moving Average	27.02
200-Day Moving Average	28.02
Relative Strength Index (RSI)	51.39
Average Volume (20 Days)	544,489

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, Pfizer had revenue of GBP 44.31 billion and earned 3.17 billion in profits. Earnings per share was 0.56.

Revenue	44.31B
Gross Profit	30.92B
Operating Income	8.58B
Pretax Income	2.91B
Net Income	3.17B
EBITDA	13.71B
EBIT	8.58B
Earnings Per Share (EPS)	0.56

Full Income Statement

Balance Sheet

The company has 7.43 billion in cash and 50.70 billion in debt, giving a net cash position of -43.28 billion.

Cash & Cash Equivalents	7.43B
Total Debt	50.70B
Net Cash	-43.28B
Net Cash Per Share	n/a
Equity (Book Value)	69.07B
Book Value Per Share	12.15
Working Capital	8.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.41 billion and capital expenditures -2.27 billion, giving a free cash flow of 6.14 billion.

Operating Cash Flow	8.41B
Capital Expenditures	-2.27B
Free Cash Flow	6.14B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.78%, with operating and profit margins of 19.36% and 7.16%.

Gross Margin	69.78%
Operating Margin	19.36%
Pretax Margin	6.58%
Profit Margin	7.16%
EBITDA Margin	30.93%
EBIT Margin	19.36%
FCF Margin	13.86%

Dividends & Yields

This stock pays an annual dividend of 1.32, which amounts to a dividend yield of 5.02%.

Dividend Per Share	1.32
Dividend Yield	5.02%
Dividend Growth (YoY)	0.47%
Years of Dividend Growth	n/a
Payout Ratio	222.18%
Buyback Yield	0.42%
Shareholder Yield	5.44%
Earnings Yield	2.66%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 1.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	n/a